Mutual Fund Details

LIC MF Healthcare Fund Direct - Growth

Name: LIC MF Healthcare Fund Direct - Growth
Brand: LIC Mutual Fund

Equity Pharma

NAV

₹30.5103

as on 30 Apr 2025, 11:33 PM

₹-0.0100(0.03%)

Last Change

Scheme Ratings

rated by Value Research

Pharma

Rankings based on | as on Invalid date

Download the Paytm Money app now!

Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.

Zero brokerage for 30 days
Zero account opening fees
Zero AMC for life

Scan QR code to download the app

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,56,106

₹1,61,997

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹61,997

Profit (absolute return)

62.00%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

0.44%

In the last 6 months

4.75%

In the last 1 year

17.09%

In the last 3 years

62.00%

In the last 5 years

134.59%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

LIC MF Healthcare Fund Direct - Growth

as of 31 Mar 2025, 05:30 AM

₹82.69 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.

1.22%

Expense Ratio

Plan

Growth

1.97%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Mar 2025

Sort By

Value

Sector

Healthcare

91.70%

₹75.83 Cr

Chemicals

6.33%

₹5.23 Cr

Others

1.97%

₹1.63 Cr

Sectors Holding in this Mutual Fund

as on 31 Mar 2025

Sort By

Value

Sector

Healthcare

91.70%

₹75.83 Cr

Chemicals

6.33%

₹5.23 Cr

Others

1.97%

₹1.63 Cr

Companies Holding in this Mutual Fund

as on 31 Mar 2025

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

11.37%

₹9.40 Cr

Piramal Pharma Ltd.

6.25%

₹5.17 Cr

JB Chemicals & Pharmaceuticals Ltd.

5.96%

₹4.93 Cr

Glenmark Pharmaceuticals Ltd.

5.90%

₹4.88 Cr

Cipla Ltd.

5.80%

₹4.80 Cr

Others

64.72%

₹53.52 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Mar 2025

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

11.37%

₹9.40 Cr

Piramal Pharma Ltd.

6.25%

₹5.17 Cr

JB Chemicals & Pharmaceuticals Ltd.

5.96%

₹4.93 Cr

Glenmark Pharmaceuticals Ltd.

5.90%

₹4.88 Cr

Cipla Ltd.

5.80%

₹4.80 Cr

Others

64.72%

₹53.52 Cr

View All

Funds in this Category

This fund's returns:

17.43%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

Tata India Pharma & HealthCare Fund Direct-Growth

About LIC MF Healthcare Fund Direct - Growth

LIC MF Healthcare Fund Direct - Growth is a Equity mutual fund scheme from LIC Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹82.69 Crores and the latest NAV decalared is ₹30.510 as on 01 May 2025 at 7:47 am.

LIC MF Healthcare Fund Direct - Growth scheme return performance in last 1 year is 17.09%, in last 3 years is 62.00% and 204.49% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.